Sale!

BARD1 Gene Breast Cancer Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BARD1 gene plays a critical role in DNA repair mechanisms, and mutations in this gene have been associated with an increased susceptibility to breast cancer. Recognizing the significance of early detection and intervention, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the BARD1 gene. This test is a crucial tool for individuals with a family history of breast cancer or those deemed at high risk, providing them with the opportunity to take proactive measures in managing their health.

The testing process involves a simple sample collection, followed by comprehensive analysis to detect any genetic abnormalities linked to breast cancer susceptibility. With a cost of 4400 AED, the test represents a valuable investment in personal health, offering insights that could lead to early detection and more effective management of breast cancer risk. Conducted in the state-of-the-art facilities of DNA Labs UAE, clients are assured of accurate, reliable results and the support of expert genetic counselors to interpret their findings and guide them through their next steps.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BARD1 Gene Breast Cancer Susceptibility to Genetic Test

At DNA Labs UAE, we offer the BARD1 Gene Breast Cancer Susceptibility to Genetic Test at a cost of AED 4400.0. This test helps in assessing an individual’s susceptibility to breast cancer by analyzing the BARD1 gene.

Test Details

The BARD1 gene is a tumor suppressor gene that plays a crucial role in DNA repair and cell cycle regulation. Mutations in the BARD1 gene have been associated with an increased risk of developing breast cancer.

Our genetic testing technique, NGS (Next-Generation Sequencing), allows for the simultaneous analysis of multiple genes, including the BARD1 gene. This test can identify specific mutations or variants in the BARD1 gene that may increase the risk of developing breast cancer.

NGS genetic testing for BARD1 gene mutations can be used in clinical settings to assess an individual’s susceptibility to breast cancer. This information is valuable for personalized risk assessment, early detection, and preventive measures.

It’s important to note that a positive result from a genetic test does not guarantee that an individual will develop breast cancer, but it indicates an increased risk. Therefore, genetic counseling is typically recommended before and after NGS testing. This helps individuals understand the implications of their results and make informed decisions regarding their healthcare.

Test Components and Price

  • Test Name: BARD1 Gene Breast Cancer Susceptibility to Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED

Report Delivery and Method

  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology

Test Type, Doctor, and Test Department

  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the BARD1 Gene Breast Cancer Susceptibility to Genetic Test, it is important to provide the clinical history of the patient. This includes information about the patient’s family members who have been affected by BARD1 Gene Breast Cancer. A genetic counseling session may also be conducted to draw a pedigree chart of the family members affected by BARD1 Gene Breast Cancer.

Genetic counseling is crucial in understanding the family’s genetic history and assessing the risk of developing breast cancer.

Test Name BARD1 Gene Breast cancer susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for BARD1 Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with BARD1 Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene BARD1
Test Details

The BARD1 gene is a tumor suppressor gene that plays a role in DNA repair and cell cycle regulation. Mutations in the BARD1 gene have been associated with an increased risk of developing breast cancer.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including the BARD1 gene. This type of test can identify specific mutations or variants in the BARD1 gene that may increase the risk of developing breast cancer.

NGS genetic testing for BARD1 gene mutations can be used in clinical settings to assess an individual’s susceptibility to breast cancer. This information can be valuable for personalized risk assessment, early detection, and preventive measures.

It’s important to note that a positive result from a genetic test does not guarantee that an individual will develop breast cancer, but it indicates an increased risk. Genetic counseling is typically recommended before and after NGS testing to help individuals understand the implications of their results and make informed decisions regarding their healthcare.